The Miami Stem Cell Therapy Podcast

miamistemcelltherapy
  • 0.0 (0)
  • MEDICINE

The Miami Stem Cell Podcast by STEMS Health Regenerative Medicine in Miami Beach, Florida, is an informational, synthetic narrated podcast designed to educate listeners about the science and practice of regenerative medicine. Each episode delivers clear, evidence-based insights on topics such as stem cell therapy, PRP, exosomes, peptides, and anti-aging innovations, reflecting the clinical expertise of Dr. Ankeet Choxi and Dr. Jarred Mait. Created for patients and wellness-minded listeners, the podcast simplifies complex medical topics while emphasizing safety, transparency, and real-world applications - helping you stay informed about the latest advances in regenerative and longevity medicine. To learn more about regenerative and restorative treatments, visit stemshealthregenerativemedicine.com or schedule a consultation at our Miami Beach clinic, located at 925 W 41st St #300A, Miami Beach, FL 33140, (305) 677.0565.

  1. Ep 35 Can Stem Cell Therapy Support Both Pain Relief and Longevity?

    4 DAYS AGO

    Ep 35 Can Stem Cell Therapy Support Both Pain Relief and Longevity?

    Can stem cell therapy support both pain relief and longevity? It’s a question that’s coming up more often as people start to think about health in a broader way. Not long ago, stem cell therapy was mostly discussed in terms of specific problems- joint pain, tendon injuries, or chronic inflammation in one area of the body. Today, patients are asking a bigger question. Can something that helps with pain also support long-term health? To answer that, it helps to break it into two parts. First, what does stem cell therapy actually do for pain? And second, what do we really mean by longevity? In clinical practice, stem cell therapy is primarily used for targeted treatment. That means focusing on a specific area- like a knee, shoulder, or spine. The goal is to reduce inflammation, support tissue repair, and improve function. Biologically, stem cells work through signaling. They release molecules that help regulate inflammation and guide the body’s repair process. Over time, this can lead to improvements in pain and mobility. But it’s not immediate. It’s a gradual process. Now let’s look at longevity. Longevity isn’t just about living longer. It’s about how well the body functions over time- how it recovers, how it handles stress, and how it maintains mobility and independence. So where do these two ideas overlap? One connection is inflammation. Inflammation plays a role in both localized pain and broader aging processes. When you reduce inflammation in a joint, for example, you may also make it easier to stay active. And staying active supports overall health. If pain improves, movement improves. If movement improves, other systems benefit. That’s where stem cell therapy can indirectly support long-term health. But it’s important to be clear. Stem cell therapy is not a direct longevity treatment. And this is where the distinction between targeted and systemic approaches matters. Targeted treatments are designed to address a specific issue. Systemic approaches aim to influence the body more broadly. They’re different strategies, and they serve different purposes. So if you’re asking whether stem cell therapy can do both- relieve pain and support longevity- the most accurate answer is this: It can improve conditions that contribute to long-term health, but it’s not a standalone solution for longevity itself. That’s why your goal matters. Are you trying to reduce pain? Improve function? Or support overall wellness? Each of those requires a different approach. The most useful step is to align your expectations with what the therapy is actually designed to do. Because when that alignment is there, the results tend to make a lot more sense. Stem cell therapy can be a powerful tool for improving how you feel and how you move. And those improvements can absolutely contribute to a healthier, more active life over time. But longevity is a bigger picture. And it’s built from how all those pieces work together.

    5 min
  2. Ep 34 Are Stem Cells Illegal in the United States?

    6 DAYS AGO

    Ep 34 Are Stem Cells Illegal in the United States?

    Are stem cells illegal in the United States? It’s one of the most common questions people ask when they start looking into regenerative medicine. And it makes sense. There’s a lot of mixed information out there. Some sources suggest these treatments are banned. Others make it seem like anything is available if you just look hard enough. The reality is more nuanced. Stem cell therapy is not illegal in the United States. But it is regulated. And understanding that distinction is key to making sense of what’s actually available. In the U.S., stem cell therapies fall under the oversight of the U.S. Food and Drug Administration, or FDA. Their role is to evaluate biologic treatments for safety and to determine how they can be used in clinical settings. But the FDA doesn’t treat all stem cell therapies the same. Instead, they use a framework that separates treatments based on how the cells are sourced, processed, and used. At a high level, there are a few important factors that determine whether a treatment can be offered in a clinic. One is something called minimal manipulation. That refers to how much the cells have been altered outside the body. Another is homologous use. That means the cells are being used for the same basic function they perform naturally. And another factor is whether the cells come from the same patient receiving the treatment. When those criteria are met, certain therapies can be performed under established guidelines. When they’re not, the treatment usually falls into a different category that requires formal FDA approval, often through clinical trials. This is why you’ll sometimes hear terms like “361 therapies” and “351 therapies.” 361 therapies generally involve minimally manipulated cells used in a way that aligns with their natural function. These are the types of treatments more commonly available in clinical practice. 351 therapies involve more complex processing or different intended uses, and they typically require a higher level of regulatory approval before they can be widely offered. So when someone asks whether stem cells are legal, the more accurate answer is this: Some treatments are available within the current regulatory framework, and others are still in the research and approval phase. That brings up another common question. Why are some treatments offered in other countries that aren’t available in the United States? The answer comes down to differences in regulation. Different countries have different standards for approving biologic therapies. Some allow treatments to be introduced more quickly, with fewer requirements for long-term data. Others, like the United States, emphasize a more structured process that includes safety evaluation, evidence gathering, and ongoing monitoring. That approach can slow things down. But it’s designed to ensure that treatments are delivered in a controlled and accountable way. It also helps explain why availability doesn’t always equal advancement. Just because something is offered somewhere doesn’t necessarily mean it has gone through the same level of evaluation. There are also a few misconceptions that tend to come up around this topic. One is the idea that all stem cell treatments require FDA approval before they can be used. That’s not entirely accurate. Some therapies fall within existing guidelines and can be performed without going through a full approval process. Another is the belief that U.S. clinics are limited because they lack access to certain technologies. In most cases, the limitation isn’t capability. It’s compliance with regulatory standards. And then there’s the assumption that regulation prevents innovation. In reality, research in regenerative medicine is ongoing. Many therapies are being studied in clinical trials, and new approaches continue to be developed within the regulatory system. So what should patients take away from all of this? If you’re considering stem cell therapy, it’s important to look beyond general claims and ask specific questions. What type of treatment is being offered? How are the cells sourced and processed? Does the therapy fall within established regulatory guidelines? And what kind of evidence supports its use? These questions help clarify not just what’s available, but how it fits within the broader framework of safety and clinical practice. Because ultimately, the goal of regulation is not to limit access. It’s to ensure that treatments are delivered responsibly, with attention to both safety and outcomes. Stem cell therapy is not illegal in the United States. But it does exist within a system designed to balance innovation with oversight. And understanding that system can make it much easier to navigate your options and make informed decisions about care.

    6 min
  3. Ep 33 How Long Should a Stem Cell Therapy Clinic Follow You After Treatment?

    30 APR

    Ep 33 How Long Should a Stem Cell Therapy Clinic Follow You After Treatment?

    How Long Should a Stem Cell Therapy Clinic Follow You After Treatment? One of the most overlooked parts of stem cell therapy isn’t the procedure itself. It’s what happens after. When most people think about regenerative medicine, they focus on the treatment. How many cells are used. Where they’re injected. What condition is being treated. But stem cell therapy doesn’t end when the procedure is over. In many ways, that’s where the process actually begins. These treatments work by influencing biological activity over time. Cells signal. They interact with surrounding tissue. They help regulate inflammation and support repair processes. And all of that unfolds gradually. Which is why follow-up care isn’t optional. It’s a core part of the treatment. So the question becomes: how long should a clinic actually follow you after stem cell therapy? The answer is longer than most people expect. Immediately after treatment, the focus is usually on recovery and early response. You might experience some mild inflammation. You may notice subtle changes in pain or mobility. But these early responses don’t tell the whole story. Regenerative therapies are not designed for instant results. They’re designed to support the body’s natural repair mechanisms, which take time. That’s why a structured follow-up plan is important. A typical timeline often starts with an initial check-in somewhere around two to four weeks after the procedure. At that stage, the goal is to assess how the body is responding. Are there any concerns? Are symptoms changing in a meaningful way? From there, follow-up usually continues into the six to twelve week range. This is where you start to see more measurable changes in function. Mobility may improve. Pain levels may shift. Activity tolerance can increase. And then there’s the longer-term evaluation, often three to six months out, or even beyond. This is where the real picture comes into focus. Are the improvements sustained? Is function continuing to improve? Has the treatment meaningfully impacted quality of life? These checkpoints are not arbitrary. They align with how tissue repair actually happens in the body. And without them, it becomes difficult to understand whether a treatment is truly working. But follow-up isn’t just about timing. It’s also about what’s being tracked. Effective follow-up involves structured outcome monitoring. That includes things like pain levels, mobility, and functional performance. It may include how well you’re returning to normal activities. And in some cases, it can involve imaging or additional diagnostics. The goal is to build a complete picture over time. Because without that, you’re left with isolated observations instead of meaningful trends. And that leads to another important point. Not all follow-up protocols are created equal. There are certain red flags patients should be aware of. For example, if a clinic schedules little to no follow-up beyond the procedure itself, that’s something to pay attention to. If there’s no clear timeline for evaluation, or no defined way to measure progress, that can make it difficult to assess outcomes. And if communication drops off after treatment, patients may be left without guidance during a process that is still unfolding. Regenerative medicine is not a one-time event. It’s a process that requires observation and, in some cases, adjustment. So what should patients expect? A comprehensive approach to stem cell therapy should include a clearly defined follow-up plan. You should know when you’ll be evaluated. What will be measured. And how your progress will be interpreted. There should be ongoing communication. Guidance on recovery and activity. And a structured way to track how you’re doing over time. It’s also reasonable to ask these questions before treatment begins. How often will I be seen after the procedure? What outcomes are you tracking? And how will decisions be made if adjustments are needed? Because ultimately, follow-up is about continuity. It connects the procedure to the outcome. And it helps ensure that what was done during treatment translates into meaningful, lasting results. Stem cell therapy is often discussed as a single event. But in reality, it’s a process that unfolds over weeks and months. And without structured follow-up, it’s difficult to fully understand that process or maximize its potential. When patients understand this, they’re better equipped to evaluate care, ask the right questions, and make more informed decisions.

    6 min
  4. Ep 32 Exosomes Versus Stem Cells: Understanding the Mechanism, Not the Marketing

    29 APR

    Ep 32 Exosomes Versus Stem Cells: Understanding the Mechanism, Not the Marketing

    Today we’re going to unpack a topic that’s getting a lot of attention in regenerative medicine right now - exosomes versus stem cells. You’ve probably seen this framed as a comparison. Maybe even a choice. One or the other. Which is better? But the reality is more nuanced than that. To understand what’s really going on, we need to step back and look at the biology behind both. Let’s start with stem cells. In regenerative medicine, stem cells are often described as the drivers of healing. And while that’s true in a general sense, it’s not because they simply replace damaged tissue. A big part of what stem cells actually do comes down to signaling. Once introduced into the body, stem cells release a range of signaling molecules. These signals help regulate inflammation, coordinate repair, and influence how surrounding cells behave. So instead of acting like replacement parts, stem cells act more like coordinators. They help guide the body’s natural repair processes. Now let’s talk about exosomes. Exosomes are small particles - technically called extracellular vesicles - that are released by cells, including stem cells. You can think of them as messengers. They carry proteins, lipids, and genetic material, and they help cells communicate with each other. They’re involved in processes like reducing inflammation, supporting repair, and transferring biological information from one cell to another. So when people talk about exosome therapy, they’re talking about using these signaling messengers directly. And this is where things start to connect. One of the most important points - and one that often gets lost in marketing - is that stem cells naturally produce exosomes. That means when stem cells are used in treatment, they are already releasing exosomes as part of their normal function. This process is known as paracrine signaling. It’s how cells influence their environment by sending out signals. So from a biological standpoint, stem cells are the source, and exosomes are one of the outputs. That’s why framing this as exosomes versus stem cells can be misleading. They’re not completely separate. They’re part of the same system. Both contribute to healing. Both play a role in signaling. And both depend on the context in which they’re used. So why does the comparison exist? In many cases, it comes down to how these therapies are presented. Exosomes are sometimes positioned as a simpler or more advanced alternative. Something that can replace stem cells altogether. But that kind of framing tends to oversimplify the biology. The more accurate way to think about it is this: Stem cells and exosomes are connected. They work within the same communication network inside the body. And the effectiveness of either approach depends on the specific situation. There are cases where exosomes may be considered as part of a treatment strategy. For example, in situations where cell-based therapies may not be appropriate, or where additional signaling support could be beneficial. There are also protocols where therapies may be combined, depending on the goals of care. But these decisions are not made in isolation. They’re based on factors like the patient’s condition, the type of tissue involved, the extent of damage, and the desired outcome. In other words, it’s not about choosing one over the other in a vacuum. It’s about understanding how each option contributes to the broader goal of supporting repair. And that requires looking at the underlying communication pathways - how signals are sent, how cells respond, and how those interactions influence healing. So if you’re exploring regenerative therapies, it can be helpful to reframe the question. Instead of asking, “Are exosomes better than stem cells?” A more useful question might be, “How do these therapies work within the body’s natural repair process?” Because that’s where the real answer lives. Stem cells and exosomes are biologically connected. Exosomes are one of the ways stem cells do their work. And treatment effectiveness depends on context - not just the label attached to the therapy. When you focus on the mechanism instead of the marketing, the picture becomes much clearer. And that clarity can lead to better conversations, better expectations, and more informed decisions.

    6 min
  5. Ep. 31 Cell Potency vs Volume: Why More Isn’t Always Better in Stem Cell Therapy

    28 APR

    Ep. 31 Cell Potency vs Volume: Why More Isn’t Always Better in Stem Cell Therapy

    To learn more about regenerative and restorative stem cell therapy treatments, visit www.stemshealthregenerativemedicine.com or schedule a consultation at our Miami Beach clinic, located at 925 W 41st St #300A, Miami Beach, FL 33140, You can also reach us by phone at (305) 677.0565. Potency vs Volume: Why More Isn’t Always Better in Stem Cell Therapy Today’s question is one that comes up in almost every regenerative medicine consultation: Does more stem cells actually mean better results? It’s a reasonable assumption. In many areas of medicine, higher doses often lead to stronger effects. So when patients hear about treatments involving 50 million, 100 million, or even more cells, it sounds like more must be better. But stem cell therapy doesn’t really work that way. The more important concept to understand is something called cell potency versus volume. Volume is straightforward. It’s the number of cells being delivered during a treatment. Potency is different. Potency refers to how biologically active those cells are. How well they communicate. How effectively they respond to damaged tissue. And how capable they are of supporting repair. And in many cases, potency matters far more than volume. At a biological level, stem cells don’t just act by becoming new tissue. Much of their role comes from signaling - releasing molecules that help regulate inflammation, coordinate healing, and influence surrounding cells. So the question becomes less about how many cells are present, and more about how well those cells are functioning. One of the reasons higher cell counts don’t always lead to better outcomes is that the body has limits. Target tissues can only accommodate so many cells at once. Beyond that point, additional cells may not integrate effectively. In some cases, they may even interfere with each other’s signaling. There’s also something known as diminishing returns. After a certain threshold, adding more cells doesn’t proportionally increase the regenerative effect. So you can end up with a situation where a smaller number of highly potent cells actually performs better than a much larger number of lower-quality cells. Another key factor here is cell viability. Not every cell in a preparation is necessarily alive and functional at the time of injection. Some may be damaged during processing. Others may simply not be capable of contributing to the repair process. So when you hear a high cell count, it doesn’t always tell you how many of those cells are actually doing meaningful work. Viability, signaling capacity, and responsiveness to the tissue environment all play a role in how effective a treatment will be. There’s also the issue of how the cells are prepared. In some cases, cells are expanded in laboratory settings to increase their numbers. While that can raise the total count, repeated expansion cycles can change how those cells behave. Over time, cells may lose some of their signaling efficiency. Their ability to adapt to stress may decrease. And their overall regenerative capacity can be affected. So again, you’re seeing a tradeoff between quantity and biological integrity. And then there’s something that often gets overlooked entirely - how the cells are delivered. Stem cell therapy is not a standardized, one-size-fits-all procedure. It requires precision. Accurate diagnosis matters. Knowing exactly where the problem is. Injection technique matters. Placing cells in the correct location is critical. And treatment planning matters. Deciding how much to use, when to use it, and how it fits into a broader care plan. In many cases, these factors have a greater impact on outcomes than the total number of cells being used. So what should patients focus on? Instead of asking, “How many cells am I getting?”, it’s often more useful to ask a different set of questions. How are the cells being handled? What is their viability? What is the physician’s experience with this type of procedure? And how is the treatment plan tailored to my specific condition? Because ultimately, stem cell therapy is not about maximizing numbers. It’s about optimizing biology. It’s about delivering cells that are viable, functional, and capable of interacting with the body in a meaningful way. When you understand the difference between potency and volume, you can start to see past some of the marketing language and focus on what actually drives results. And that’s where more informed decisions begin. Disclaimer The information provided in this podcast episode is for educational and informational purposes only and is not intended as medical advice. Treatments and outcomes described may not be appropriate for every individual. Always consult a licensed healthcare provider to determine the best course of care for your specific needs. Certain regenerative medicine procedures discussed – such as stem cell therapy, exosome therapy, or other biologic treatments – may be considered investigational or not FDA-approved for all conditions. Florida law requires that we disclose this status. While these procedures are offered in accordance with state and federal guidelines, their safety and efficacy have not been fully established by the U.S. Food and Drug Administration. Results vary, and no guarantee of specific outcome or benefit is implied. All medical procedures involve potential risks, which should be discussed with your treating provider prior to treatment. © STEMS Health Regenerative Medicine, Miami Beach, Florida. All rights reserved.

    6 min
  6. Ep 30 From Evaluation to Injection: What to Expect During a MUSE Cell Procedure

    2 APR

    Ep 30 From Evaluation to Injection: What to Expect During a MUSE Cell Procedure

    To learn more about regenerative and restorative stem cell therapy treatments, visit www.stemshealthregenerativemedicine.com or schedule a consultation at our Miami Beach clinic, located at 925 W 41st St #300A, Miami Beach, FL 33140, You can also reach us by phone at (305) 677.0565. ------------- From Evaluation to Injection: What to Expect During a MUSE Cell Procedure Regenerative medicine has become an area of growing interest for patients dealing with chronic joint and spine pain. As more people explore alternatives to surgery or long-term medication, many are curious about what actually happens during a regenerative procedure. One example currently being studied is MUSE cell therapy, and understanding the process—from evaluation to injection—can help patients better understand what to expect. At STEMS Health Regenerative Medicine in Miami Beach, physicians approach regenerative therapies with a structured and physician-led process. Every procedure begins with a detailed medical evaluation to understand the underlying cause of a patient’s symptoms. Joint pain or chronic back discomfort can originate from several different structures within the musculo-skeletal system. Cartilage wear, tendon degeneration, ligament injuries, or spinal disc changes can all contribute to pain. Identifying the precise source of the problem is essential before any regenerative therapy is considered. The first step is a consultation and physical examination. During this visit, physicians review the patient’s medical history, prior injuries, previous treatments, and current symptoms. This evaluation helps determine whether regenerative medicine may be appropriate within the patient’s overall treatment plan. Diagnostic imaging is also an important part of the process. Imaging studies such as MRI scans or ultrasound allow physicians to visualize the internal structures of joints, tendons, and spinal discs. These images help confirm the diagnosis and identify the exact location of tissue damage. At STEMS Health, careful imaging review plays a key role in determining whether regenerative therapy may be considered. If a patient is determined to be a potential candidate, the next stage involves preparing the biologic therapy used in the procedure. Regenerative medicine relies on careful handling of biologic materials, and physicians follow strict preparation protocols to maintain sterility and integrity. Proper biologic preparation is an essential step in ensuring the therapy is administered safely and appropriately. The procedure itself is typically performed using image-guided injection techniques. Imaging tools such as ultrasound allow physicians to see soft tissue structures in real time while performing the injection. For certain spine conditions, fluoroscopic imaging may be used to guide needle placement with precision. These technologies allow physicians to deliver the biologic therapy directly to the affected tissue, whether that involves a joint, tendon, ligament, or spinal structure. Most regenerative injections are performed in an outpatient clinical setting and typically take less than an hour to complete. Because these procedures are minimally invasive, patients usually return home the same day. Some people may experience mild soreness or temporary inflammation around the injection site, which can occur as part of the body’s natural response to the treatment. Recovery timelines vary depending on the patient’s condition and the severity of the tissue degeneration. Regenerative therapies are designed to support natural repair processes, so improvements may develop gradually over time rather than immediately. Follow-up care is another important part of regenerative medicine. Physicians monitor progress, assess symptom changes, and guide patients through appropriate rehabilitation or activity adjustments when necessary. At STEMS Health Regenerative Medicine, the goal is to combine careful medical evaluation with advanced imaging-guided procedures to ensure that regenerative therapies are considered responsibly. For patients exploring regenerative medicine, understanding the full process—from consultation and imaging to the injection procedure and follow-up care—can help provide clarity when evaluating treatment options for chronic joint or spine conditions. Disclaimer The information provided in this podcast episode is for educational and informational purposes only and is not intended as medical advice. Treatments and outcomes described may not be appropriate for every individual. Always consult a licensed healthcare provider to determine the best course of care for your specific needs. Certain regenerative medicine procedures discussed – such as stem cell therapy, exosome therapy, or other biologic treatments – may be considered investigational or not FDA-approved for all conditions. Florida law requires that we disclose this status. While these procedures are offered in accordance with state and federal guidelines, their safety and efficacy have not been fully established by the U.S. Food and Drug Administration. Results vary, and no guarantee of specific outcome or benefit is implied. All medical procedures involve potential risks, which should be discussed with your treating provider prior to treatment. © STEMS Health Regenerative Medicine, Miami Beach, Florida. All rights reserved.

    6 min
  7. Ep 29 Who May Be a Candidate for MUSE Cell Therapy in Miami Beach?

    31 MAR

    Ep 29 Who May Be a Candidate for MUSE Cell Therapy in Miami Beach?

    To learn more about regenerative and restorative stem cell therapy treatments, visit www.stemshealthregenerativemedicine.com or schedule a consultation at our Miami Beach clinic, located at 925 W 41st St #300A, Miami Beach, FL 33140, You can also reach us by phone at (305) 677.0565. -------------   Who May Be a Candidate for MUSE Cell Therapy in Miami Beach? Regenerative medicine has attracted growing attention in recent years, especially among patients dealing with chronic joint and spine pain. As more people explore alternatives to surgery or long-term medication, one question comes up frequently: who may actually be a candidate for regenerative therapies such as MUSE cell treatment? Understanding candidacy is an important first step. Regenerative medicine is not a one-size-fits-all solution, and determining whether a patient may benefit from these therapies requires careful medical evaluation. MUSE cells, short for Multilineage Differentiating Stress Enduring cells, are a specialized population of regenerative cells that researchers have been studying for their potential role in tissue repair signaling. Scientists are interested in how these cells respond to damaged environments within the body and how they may participate in biological processes involved in healing. But before considering any regenerative therapy, physicians must first evaluate the underlying cause of a patient’s symptoms. Chronic joint pain or spine discomfort can come from many different sources, including cartilage wear, tendon degeneration, disc problems, or inflammation in surrounding tissues. Identifying the exact source of pain is critical to determining the appropriate treatment strategy. At STEMS Health Regenerative Medicine in Miami Beach, physicians begin with a structured clinical evaluation. This process typically includes a detailed medical history review, a physical examination, and diagnostic imaging. Imaging studies such as MRI scans or ultrasound allow physicians to see the internal structures of joints, tendons, ligaments, and spinal discs. These images help determine whether the tissue damage falls within ranges where regenerative therapies may be considered. Patients who explore regenerative medicine often have conditions involving degenerative joints. The shoulder, knee, hip, and elbow are common areas where wear and tear can gradually change the structure of cartilage and supporting tissues. In some cases, patients are looking for ways to preserve joint function or delay surgical procedures. Spine conditions are also sometimes evaluated in regenerative consultations. Degenerative disc disease, facet joint arthritis, and chronic lower back pain can develop when spinal structures gradually change over time. Careful imaging and clinical assessment help physicians determine whether regenerative approaches may be appropriate for certain cases. Medical history also plays a significant role in determining candidacy. Physicians review overall health factors, including previous surgeries, chronic medical conditions, medications, and lifestyle factors that may influence healing. These details help ensure that treatment decisions are made responsibly and safely. Another important part of the evaluation process involves setting realistic expectations. Regenerative medicine is an evolving field of research, and biologic therapies are designed to support the body’s natural repair processes rather than guarantee outcomes. Every patient responds differently depending on the severity of their condition and their overall health. At STEMS Health, physicians emphasize individualized treatment planning. Rather than applying a single approach to every patient, they focus on understanding each patient’s specific diagnosis, functional goals, and long-term orthopedic health. For patients experiencing chronic joint or spine conditions, a regenerative consultation provides an opportunity to better understand the available treatment options. With careful evaluation and physician guidance, patients can explore whether regenerative medicine may play a role in their broader care plan.   Disclaimer The information provided in this podcast episode is for educational and informational purposes only and is not intended as medical advice. Treatments and outcomes described may not be appropriate for every individual. Always consult a licensed healthcare provider to determine the best course of care for your specific needs. Certain regenerative medicine procedures discussed – such as stem cell therapy, exosome therapy, or other biologic treatments – may be considered investigational or not FDA-approved for all conditions. Florida law requires that we disclose this status. While these procedures are offered in accordance with state and federal guidelines, their safety and efficacy have not been fully established by the U.S. Food and Drug Administration. Results vary, and no guarantee of specific outcome or benefit is implied. All medical procedures involve potential risks, which should be discussed with your treating provider prior to treatment. © STEMS Health Regenerative Medicine, Miami Beach, Florida. All rights reserved.

    6 min
  8. Ep 28 MUSE Cells and Chronic Tendon Degeneration: What Current Research Suggests

    27 MAR

    Ep 28 MUSE Cells and Chronic Tendon Degeneration: What Current Research Suggests

    To learn more about regenerative and restorative stem cell therapy treatments, visit www.stemshealthregenerativemedicine.com or schedule a consultation at our Miami Beach clinic, located at 925 W 41st St #300A, Miami Beach, FL 33140, You can also reach us by phone at (305) 677.0565. ------------- MUSE Cells and Chronic Tendon Degeneration: What Current Research Suggests Chronic tendon degeneration is one of the most common causes of persistent joint pain, particularly in the shoulder and ankle. Conditions involving the rotator cuff or the Achilles tendon can develop slowly over time, often beginning with small structural changes in the tendon that gradually worsen with repeated stress and aging. Unlike acute tendon tears, degenerative tendon conditions involve a breakdown of the tendon’s internal structure. Tendons rely on a carefully organized network of collagen fibers known as the extracellular matrix. This structure gives the tendon its strength and elasticity, allowing it to transmit force from muscle to bone during movement. When degeneration develops, that structure begins to change. Collagen fibers become disorganized, the tendon matrix weakens, and the cells responsible for repair become less effective. These changes can lead to chronic pain, stiffness, and reduced mobility, particularly in areas of the body that experience frequent mechanical load. Because of these challenges, physicians and researchers have increasingly explored regenerative medicine approaches that focus on supporting the body’s natural healing mechanisms rather than simply managing symptoms. One area of emerging scientific interest involves a type of regenerative cell known as MUSE cells. The term MUSE stands for Multilineage Differentiating Stress Enduring cells. Researchers have studied these cells because they appear capable of responding to tissue stress and participating in biologic signaling related to repair. While research into MUSE cells is still developing, scientists are interested in how these cells may interact with damaged tissues and influence the cellular communication pathways involved in healing. Tendon repair depends heavily on the activity of fibroblasts. Fibroblasts are specialized cells responsible for producing collagen, which forms the structural backbone of tendons. When tendon degeneration occurs, fibroblast signaling can become disrupted. This disruption can slow or impair the normal repair process. Investigators studying regenerative therapies often focus on how biologic treatments may influence fibroblast activity and support extracellular matrix remodeling. Extracellular matrix remodeling is the process through which damaged tissue gradually reorganizes and rebuilds its structural framework. Two of the tendons most frequently affected by chronic degeneration are the rotator cuff in the shoulder and the Achilles tendon in the ankle. The rotator cuff helps stabilize the shoulder joint and is involved in many everyday movements, including lifting and reaching overhead. Over time, repetitive motion and age-related tissue changes can lead to degeneration of these tendons. The Achilles tendon experiences some of the highest mechanical loads in the human body. Activities such as running and jumping place tremendous strain on this structure. When the tendon’s ability to repair itself becomes compromised, chronic Achilles tendinopathy can develop. At STEMS Health Regenerative Medicine in Miami Beach, physicians regularly evaluate patients experiencing these types of musculo-skeletal conditions. Careful diagnostic assessment, including imaging studies such as MRI or ultrasound, helps determine the severity of tendon degeneration and whether regenerative treatment approaches may be considered. Regenerative orthopedic procedures often involve minimally invasive techniques that deliver biologic therapies directly to injured tissues. Physicians frequently use imaging guidance, such as ultrasound or fluoroscopy, to ensure accurate placement of treatments within the affected tendon. These procedures are typically performed in outpatient clinical environments and are designed to target damaged tissue with precision while minimizing disruption to surrounding structures. It is important to understand that regenerative therapies remain an evolving area of medical research. Treatments involving biologic cells are not guaranteed solutions, and outcomes can vary significantly depending on the patient’s condition, the severity of tissue damage, and overall health factors. For that reason, physician evaluation and individualized treatment planning are critical parts of responsible regenerative care. Research into biologic tendon repair continues to expand as scientists learn more about how cellular signaling influences tissue healing. Studies involving regenerative cells, including Muse cells, are part of a broader effort to better understand the biology of musculo-skeletal repair. As the science advances, physicians hope to gain deeper insights into how regenerative medicine may complement traditional orthopedic treatments for chronic tendon degeneration. For patients experiencing persistent tendon pain, continued research offers the possibility of new approaches that focus not only on managing symptoms but also on supporting the body’s natural repair processes. Disclaimer The information provided in this podcast episode is for educational and informational purposes only and is not intended as medical advice. Treatments and outcomes described may not be appropriate for every individual. Always consult a licensed healthcare provider to determine the best course of care for your specific needs. Certain regenerative medicine procedures discussed – such as stem cell therapy, exosome therapy, or other biologic treatments – may be considered investigational or not FDA-approved for all conditions. Florida law requires that we disclose this status. While these procedures are offered in accordance with state and federal guidelines, their safety and efficacy have not been fully established by the U.S. Food and Drug Administration. Results vary, and no guarantee of specific outcome or benefit is implied. All medical procedures involve potential risks, which should be discussed with your treating provider prior to treatment. © STEMS Health Regenerative Medicine, Miami Beach, Florida. All rights reserved.

    7 min
See All (35)

About

The Miami Stem Cell Podcast by STEMS Health Regenerative Medicine in Miami Beach, Florida, is an informational, synthetic narrated podcast designed to educate listeners about the science and practice of regenerative medicine. Each episode delivers clear, evidence-based insights on topics such as stem cell therapy, PRP, exosomes, peptides, and anti-aging innovations, reflecting the clinical expertise of Dr. Ankeet Choxi and Dr. Jarred Mait. Created for patients and wellness-minded listeners, the podcast simplifies complex medical topics while emphasizing safety, transparency, and real-world applications - helping you stay informed about the latest advances in regenerative and longevity medicine. To learn more about regenerative and restorative treatments, visit stemshealthregenerativemedicine.com or schedule a consultation at our Miami Beach clinic, located at 925 W 41st St #300A, Miami Beach, FL 33140, (305) 677.0565.

Information